Skip to main content
Clinical Trials/NCT03044782
NCT03044782
Completed
Not Applicable

Barriers to Healthcare and Quality of Life for Central Centrifugal Cicatricial Alopecia Patients

Northwestern University1 site in 1 country34 target enrollmentStarted: August 2016Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
34
Locations
1
Primary Endpoint
Quantified Quality of Life Survey Responses

Overview

Brief Summary

The purpose of the current project is twofold; first to determine what personal, historical, logistical, and environmental factors preclude women from obtaining medical care for CCCA hair loss. Because damage from CCCA is irreversible, early identification and treatment is paramount to limiting the negative ramifications of the disease. Second, to investigate how CCCA hair loss, a common occurrence in the Black population, can be a significant psychological impediment to lives of affected Black women. Based on previous research on the psychosocial impact of generalized hair loss in Black women, it is fair to consider that CCCA hair loss also leads to problems with self-esteem and participation in daily life activities. This research, the first of its kind, will add to existing knowledge of CCCA by investigating the quality of life and barriers to care of patients with this condition. The goal of this study is to illuminate what stands in the way of secondary and tertiary prevention of CCCA patients and tailor treatment strategies to address their needs. The results of this study will be instrumental in modifying dermatology resident training, adding to existing dermatology management guidelines, and even developing public health advocacy programming.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Evaluated in the Northwestern Dermatology Department between October 1, 2015 and September 30,
  • Evaluated by any faculty physician.
  • Diagnosed with CCCA.
  • Age 18 or older.
  • All subjects must have given signed informed consent prior to participation in study.

Exclusion Criteria

  • Non-English speakers (interpreters not available)

Outcomes

Primary Outcomes

Quantified Quality of Life Survey Responses

Time Frame: Duration of study-approximately 2 years

Quantified Barriers to Care Survey Responses

Time Frame: Duration of study-approximately 2 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Roopal Kundu

Assistant Professor, Dermatology

Northwestern University

Study Sites (1)

Loading locations...

Similar Trials